CALVIN P. BRITTON, DPM
Podiatry in Little Rock, AR
License number
Arkansas 112
Category
Podiatry
Type
Podiatrist
Address
Address
10018 W MARKHAM, Little Rock, AR 72205
Phone
(501) 534-8888
(501) 534-8891 (Fax)
(501) 534-8891 (Fax)
Personal information
See more information about CALVIN P. BRITTON at radaris.comName
Address
Phone
1335 Airport Rd, Hot Springs, AR 71913
289 Sunshine Village Sq, Royal, AR 71968
6105 Father Tribou St, Little Rock, AR 72205
289 Sunshine Village Sq, Royal, AR 71968
1 Pine Way Ct, Little Rock, AR 72211
Professional information
Calvin P Britton, Little Rock AR
Specialties:
Podiatrist
Address:
10018 W Markham St, Little Rock, AR 72205
Novel Wound Healing Composition Not Containing Bovine-Derived Activating Reagents
US Patent:
2003000, Jan 9, 2003
Filed:
Jul 3, 2001
Appl. No.:
09/898316
Inventors:
Calvin Britton - Little Rock AR, US
Alex Dellinger - Little Rock AR, US
Jim Limbird - Little Rock AR, US
Carl Keller - Little Rock AR, US
Charles Worden - , US
Alex Dellinger - Little Rock AR, US
Jim Limbird - Little Rock AR, US
Carl Keller - Little Rock AR, US
Charles Worden - , US
International Classification:
A01N063/00, A01N065/00, A01N001/02, A61K035/14, A61K035/16
US Classification:
424/093720, 435/002000, 424/529000, 424/530000, 424/532000
Abstract:
A wound care preparation free from bovine-derived activating agents is disclosed for use in wound care, for both topical wounds and surgical wounds. The preparation is isolated by first obtaining an amount of whole blood from the patient and treating the whole blood with one or more anti-clotting agents, subjecting the whole blood to a centrifugation process to obtain an amount of platelet-rich plasma, adding to the platelet-rich plasma an amount of anti-clotting neutralizing agent, and mixing the platelet-rich plasma with a structural matrix to increase viscosity of the preparation. In use, the viscous preparation can be applied directly to a wound or surgery incision and the viscous preparation may be mixed with other wound healing agents, growth matrices, or promoters such as anti-fungal agents, anti-biotic agents, and preservatives.
Novel Wound Healing Composition Not Containing Bovine-Derived Activating Reagents
US Patent:
2003015, Aug 14, 2003
Filed:
Dec 17, 2002
Appl. No.:
10/323861
Inventors:
Calvin Britton - Little Rock AR, US
Alex Dellinger - Little Rock AR, US
Jim Limbird - Little Rock AR, US
Carl Keller - Little Rock AR, US
Charles Worden - Fayetteville AR, US
Alex Dellinger - Little Rock AR, US
Jim Limbird - Little Rock AR, US
Carl Keller - Little Rock AR, US
Charles Worden - Fayetteville AR, US
International Classification:
A61K035/14
US Classification:
424/529000
Abstract:
A wound care preparation free from bovine-derived activating agents is disclosed for use in wound care, for both topical wounds and surgical wounds. The preparation is isolated by first obtaining an amount of whole blood from the patient and treating the whole blood with one or more anti-clotting agents, subjecting the whole blood to a centrifugation process to obtain an amount of platelet-rich plasma, adding to the platelet-rich plasma an amount of anti-clotting neutralizing agent, and mixing the platelet-rich plasma with a structural matrix to increase viscosity of the preparation. In use, the viscous preparation can be applied directly to a wound or surgery incision and the viscous preparation may be mixed with other wound healing agents, growth matrices, or promoters such as anti-fungal agents, anti-biotic agents, and preservatives.
Method Of Stimulating Blood-Derived Components Using No Added Thrombin Or Other Agonist
US Patent:
2005022, Oct 13, 2005
Filed:
Apr 8, 2004
Appl. No.:
10/821747
Inventors:
Calvin Britton - Little Rock AR, US
Carl Keller - Little Rock AR, US
Carl Keller - Little Rock AR, US
International Classification:
A61M037/00
US Classification:
604004010
Abstract:
The present disclosure contemplates the creation of an active turgid gas liquid interface as means to stimulate various blood components contained within a blood sample, thereby facilitating the formation of fibrin contained within the blood sample, thereby increasing the viscosity of the sample, with such sample being applied to damaged tissue and facilitating tissue repair or tissue sealing components.